| RS1451406050 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS145141656 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS145141976 |
CETP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperalphalipoproteinemia 1, Hyperalphalipoproteinemia 1 |
| RS145142090 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS145142121 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS145142157 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1KK |
| RS145142315 |
TSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 2B, Pontoneocerebellar hypoplasia |
| RS145143533 |
APOB
|
Health Risk |
Pathogenic |
Hypobetalipoproteinemia, Hypercholesterolemia |
| RS145143725 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, DYSF-related disorder |
| RS145143758 |
MFF
|
Health Risk |
Conflicting classifications of pathogenicity |
Encephalopathy due to defective mitochondrial and peroxisomal fission 2, Encephalopathy due to defective mitochondrial and peroxisomal fission 2 |
| RS1451442305 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS145144233 |
TCIRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS1451442644 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS145144527 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
WFS1-Related Spectrum Disorders, Autosomal dominant nonsyndromic hearing loss 6 |
| RS1451449404 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS145145045 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia, Inborn genetic diseases |
| RS1451455641 |
ACADVL
|
Health Risk |
Pathogenic/Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS145145840 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS145146059 |
MOCS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, MOCS1-related disorder |
| RS145146218 |
NUP93
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 12 |
| RS1451464888 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS1451472748 |
ARG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Arginase deficiency, Arginase deficiency |
| RS145148072 |
PITPNM3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 5, Cone-rod dystrophy 5 |
| RS1451486649 |
PLA2G6
|
Health Risk |
Likely pathogenic |
Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration |
| RS145148854 |
CDAN1
|
Health Risk |
Pathogenic |
Uterine corpus endometrial carcinoma, Uterine corpus endometrial carcinoma |
| RS1451493287 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1451502922 |
CUL7
|
Health Risk |
Pathogenic |
— |
| RS145150489 |
CACNA2D4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal cone dystrophy 4, CACNA2D4-related disorder |
| RS1451513451 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial colorectal cancer, Hereditary cancer-predisposing syndrome |
| RS145151396 |
PRSS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 1 |
| RS1451516304 |
EFTUD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145152331 |
STAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection, Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection |
| RS145152682 |
CYP7B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Congenital bile acid synthesis defect 3 |
| RS145153173 |
FUCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fucosidosis, Fucosidosis |
| RS145153467 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1451537398 |
ADAMTS18
|
Health Risk |
Pathogenic |
— |
| RS1451538466 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS145154247 |
SP110
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Inborn genetic diseases |
| RS145154295 |
FCHO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145154884 |
DCDC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated neonatal sclerosing cholangitis, Autosomal recessive nonsyndromic hearing loss 66 |
| RS145155035 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
CBL-related disorder, RASopathy |
| RS145155499 |
SLC11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcytic anemia with liver iron overload, Microcytic anemia with liver iron overload |
| RS1451559860 |
RIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1451563103 |
RTTN
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism due to RTTN deficiency, Microcephalic primordial dwarfism due to RTTN deficiency |
| RS1451568611 |
UNC80
|
Health Risk |
Pathogenic |
— |
| RS1451572769 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS1451575280 |
CNGB1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS145158238 |
HPS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome, Inborn genetic diseases |
| RS145158686 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS145159429 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, COL11A1-related disorder |
| RS145160045 |
PIGV
|
Health Risk |
Conflicting classifications of pathogenicity |
PIGV-related disorder, Hyperphosphatasia with intellectual disability syndrome 1 |
| RS145160213 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
DCHS1-related disorder, DCHS1-related disorder |
| RS145160881 |
CDH3
|
Health Risk |
Conflicting classifications of pathogenicity |
EEM syndrome, Inborn genetic diseases |
| RS145162376 |
AGRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 8, AGRN-related disorder |
| RS145162968 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, CNTNAP2-related disorder |
| RS145163157 |
LIFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Stuve-Wiedemann syndrome, Stuve-Wiedemann syndrome |
| RS145163592 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysosomal acid lipase deficiency, Wolman disease |
| RS145163692 |
SARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperuricemia, pulmonary hypertension |
| RS145163993 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Inborn genetic diseases |
| RS145164937 |
ABCG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia, Sitosterolemia 1 |
| RS145165171 |
CDK5RAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 3, primary |
| RS1451652011 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS145165301 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS145165730 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group I |
| RS145166164 |
ALX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Parietal foramina 2, Inborn genetic diseases |
| RS145166656 |
PHKB
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen phosphorylase kinase deficiency, Glycogen storage disease IXb |
| RS145166802 |
RIPOR2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1451674068 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS145167688 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS145167842 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Pityriasis rubra pilaris, Psoriasis 2 |
| RS145168351 |
F11
|
Health Risk |
Conflicting classifications of pathogenicity |
Plasma factor XI deficiency, Plasma factor XI deficiency |
| RS145169006 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiovascular phenotype |
| RS145169484 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Spherocytosis |
| RS1451696033 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS145169816 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1451698951 |
WDR19
|
Health Risk |
Pathogenic/Likely pathogenic |
Type IV short rib polydactyly syndrome, Type IV short rib polydactyly syndrome |
| RS145170518 |
GSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish type amyloidosis, Finnish type amyloidosis |
| RS145170911 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1451709678 |
GUSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS145171191 |
MARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145171629 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Childhood-onset schizophrenia, Familial cold autoinflammatory syndrome 2 |
| RS145171998 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145172277 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Hepatocellular carcinoma |
| RS145172612 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Schizencephaly |
| RS145172999 |
G6PC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1451730099 |
GUCY2C
|
Health Risk |
Likely pathogenic |
Meconium ileus, Meconium ileus |
| RS145173864 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Inborn genetic diseases |
| RS145175147 |
MAMLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypospadias 2 |
| RS145175293 |
TRAPPC12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145175796 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
Upshaw-Schulman syndrome, Inborn genetic diseases |
| RS145176345 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS145176701 |
TCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Transcobalamin I deficiency, Transcobalamin I deficiency |
| RS145177445 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, NBAS-related disorder |
| RS1451776623 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1451777867 |
CLN6
|
Health Risk |
Likely pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS1451780491 |
XPA
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum |
| RS1451785682 |
PLP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS145178648 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, Congenital ichthyosis of skin |
| RS145179304 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS145179638 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |